Publications by authors named "Alan M Solinger"

Claim this Profile
E
Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.
Claudia Cavelti-Weder, Andrea Babians-Brunner, Cornelia Keller, Marc A Stahel, Malaika Kurz-Levin, Alan M Solinger

Diabetes Care· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of IL-1beta improves fatigue in type 2 diabetes.
Claudia Cavelti-Weder, Romana Furrer, Cornelia Keller, Andrea Babians-Brunner, Alan M Solinger

Diabetes Care· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease.
Daniel J Lovell, Suzanne L Bowyer, Alan M Solinger

Arthritis Rheum· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety of anakinra in high-risk patients with active rheumatoid arthritis: six-month observations of patients with comorbid conditions.
Michael H Schiff, Gino DiVittorio, John Tesser, Roy Fleischmann, Joy Schechtman, Alan M Solinger

Arthritis Rheum· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rheumatic manifestations of human immunodeficiency virus.
Alan M Solinger

Curr Rheumatol Rep· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis